Glucocorticoids combined with tofacitinib in the treatment of Castleman's disease: A case report

Table 1 Some laboratory examination results of patients during hospitalization

Items	Before treatment	After treatment	Reference range
ESR in mm/h	29	6	< 38
HB in g/L	128	119	115-150
PLT as × 109/L	229	213	100-300
CRP (mg/L)	28.922	2.630	0.068-8.200
ALT in U/L	17	14	7-40
AST in U/L	15	14	13-35
ANA spectrum	Negative	Not reviewed	Negative
Acid fast bacillus smear	Acid fast bacteria not found	Not reviewed	Acid fast bacteria not found
Female tumor-associated antigen	Negative	Not reviewed	Negative
ACA	Negative	Not reviewed	Negative
IL-6 in pg/mL	5.5	Not reviewed	< 7.0
T-SPOT	Positive	Not reviewed	Negative

ACA: Anti-cardiolipin antibody; ALT: Alanine transaminase; ANA: Antinuclear antibody; AST: Aspartate aminotransferase; CRP: Hypersensitive C-reactive protein; ESR: Erythrocyte sedimentation rate; HB: Hemoglobin; IL-6: Interleukin-6; PLT: Platelets; T-SPOT: Detection of T cells in tuberculosis infection; WBC: white blood cell.